Bachem Holding (Suzhou): difference between revisions
Diff·revision 23 → 24·20:14, 6 Jan 2025
Difference between revision 23 and revision 24 of Bachem Holding (Suzhou). 8 lines changed; the page grew by 373 bytes.
| Revision 23 — 23:19, 31 Dec 2024 PrimarySrcPatia (talk) correct transposed digits 5,455 bytes ±0 | Revision 24 — 20:14, 6 Jan 2025 TallySheetTad (talk) replace bare ref with full citation 5,828 bytes +373 | ||
|---|---|---|---|
| 32 | The organisation's own material makes claims about quality systems that this wiki has not corroborated. A GMP claim in particular is not a fact until assessed against the applicable framework, and no assessment is available here.{{r|gmp,selfpub}} | 32 | The organisation's own material makes claims about quality systems that this wiki has not corroborated. A GMP claim in particular is not a fact until assessed against the applicable framework, and no assessment is available here.{{r|gmp,selfpub}} |
| 33 | 33 | ||
| + | 34 | == Product range == | |
| + | 35 | | Class | Representative listings | Documentation reported | | |
| + | 36 | |---|---|---| | |
| + | 37 | | Incretin analogues | Semaglutide, tirzepatide, retatrutide | Certificate, purity and water | | |
| + | 38 | | Research peptides | Repair and secretagogue peptides | Certificate, purity | | |
| + | 39 | | SARMs | Bulk | Certificate, purity | | |
| + | 40 | | Raw materials and oils | Bulk | Certificate, limited detail | | |
| + | 41 | ||
| 34 | == References == | 42 | == References == |
| 35 | {{reflist}} | 43 | {{reflist}} |